Lundbeck sparks bidding war with Alkermes; Pfizer closes Metsera deal
Today, a brief rundown of news from Pfizer and Alkermes, as well as updates from Kura Oncology, Gilead Sciences and Zealand Pharma that you may have missed. Pfizer said Thursday it has closed its $10 billion d…
Read guide →